Permanent alopecia following chemotherapy and bone marrow transplantation

Australas J Dermatol. 2000 May;41(2):106-8. doi: 10.1046/j.1440-0960.2000.00405.x.

Abstract

Alopecia can be a psychologically daunting prospect for people requiring cancer chemotherapy. Fortunately, most patients experience only temporary hair loss. We report the case of a 23-year-old woman with chronic myeloid leukaemia who developed permanent, near-total alopecia of her scalp, eyebrows, eyelashes, axillary and public hair following busulphan and cyclophosphamide chemotherapy which was used as conditioning prior to allogeneic bone marrow transplantation. The histology from a scalp biopsy revealed hair follicle destruction. Topical minoxidil failed to induce significant re-growth.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Alopecia / chemically induced*
  • Alopecia / drug therapy
  • Antineoplastic Agents, Alkylating / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Bone Marrow Purging / adverse effects
  • Bone Marrow Transplantation / adverse effects*
  • Busulfan / adverse effects
  • Cyclophosphamide / adverse effects
  • Female
  • Hair Follicle / drug effects
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Minoxidil / therapeutic use

Substances

  • Antineoplastic Agents, Alkylating
  • Minoxidil
  • Cyclophosphamide
  • Busulfan